参考文献/References:
[1] Gewirtz DA, Hilliker ML, Wilson EN. Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells[J]. Ra-diother Oncol, 2009, 92(3):323-328.
[2] Turesson I, Nyman J, Qvarnstr觟m F, et al. A low-dose hypersensi-tive keratinocyte loss in response to fractionated radiotherapy is as-sociated with growth arrest and apoptosis[J]. Radiother Oncol, 2010, 94(1):90-101.
[3] Vitale I, Galluzzi L, Castedo M, et al. Mitotic catastrophe:a mech-anism for avoiding genomic instability[J]. Nat Rev Mol Cell Biol, 2011, 12(6):385-392.
[4] Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs[J]. Nat Rev Cancer, 2011, 11(4):239-253.
[5] Rainey MD, Charlton ME, Stanton RV, et al. Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation[J]. Cancer Res, 2008, 68(18):7466-7474.
[6] Chalmers AJ, Lakshman M, Chan N, et al. Poly(ADP-ribose) poly-merase inhibition as a model for synthetic lethality in developing radiation oncology targets[J]. Semin Radiat Oncol, 2010, 20(4):274-281.
[7] Goodarzi AA, Jeggo P, Lobrich M. The influence of heterochromatin on DNA double strand break repair:Getting the strong, silent type to relax[J]. DNA Repair(Amst), 2010, 9(12):1273-1282.
[8] Toulany M, Kehlbach R, Rodemann HP, et al. Radiocontrast media affect radiation-induced DNA damage repair in vitro and in vivo by affecting Akt signalling[J]. Radiother Oncol, 2010, 94(1):110-116.
[9] Meyn RE, Munshi A, Haymach JV, et al. Receptor signaling as a regulatory mechanism of DNA repair[J]. Radiother Oncol, 2009, 92(3):316-322.
[10] Florczak U, Toulany M, Kehlbach R, et al. 2-Methoxyestradiol-in-duced radiosensitization is Independent of SOD but depends on in-hibition of Akt and DNA-PKcs activities[J]. Radiother Oncol, 2009, 92(3):334-338.
[11] Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer:5-year survival data from a phase 3 randomised trial, and relation between cetux-imab-induced rash and survival[J]. Lancet Oncol, 2010, 11(1):21-28.
[12] Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck[J]. N Engl J Med, 2006, 354(6):567-578.
[13] Dietz A, Wichmann G. Translational research in head and neck cancer. Biological characteristics and general aspects. HNO, 2011, 59(9):874-884.
[14] Van Den Beucken T, Ramaekers CH, Rouschop K, et al. Deficient carbonic anhydrase 9 expression in UPR-impaired cells is associ-ated with reduced survival in an acidic microenvironment[J]. Ra-diother Oncol, 2009, 92(3):437-442.
[15] S覬rensen BS, Horsman MR, Vorum H, et al. Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics[J]. Radiother Oncol, 2009, 92(3):443-449.
[16] Mujcic H, Rzymski T, Rouschop KM, et al. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3[J]. Radiother Oncol, 2009, 92(3):450-459.
[17] Zang J, Li C, Zhao LN, et al. Prognostic value of vascular endothe-lial growth factor in patients with head and neck cancer:a meta-analysis[J]. Head Neck, 2013, 35(10):1507-1514.
[18] Hui EP, Chan AT, Pezzella F, et al. Coexpression of hypoxia-in-ducible factors 1α and 2α, carbonic anhydrase IX, and vascular en-dothelial growth factor in nasopharyngeal carcinoma and relation-ship to survival[J]. Clin Cancer Res, 2002, 8(8):2595-2604.
[19] Jung YS, Vermeer PD, Vermeer DW, et al. CD200:association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma[J]. Head Neck, 2015, 37(3):327-335.
[20] Nguyen GH, Murph MM, Chang JY. Cancer stem cell radioresis-tance and enrichment:where frontline radiation therapy May fail in lung and esophageal cancers[J]. Cancers (Basel), 2011, 3(1):1232-1252.
[21] Hsu HS, Huang PI, Chang YL, et al. Cucurbitacin I inhibits tumori-genic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells[J]. Cancer, 2011, 117(13):2970-2985.
[22] Lo WL, Yu CC, Chiou GY, et al. MicroRNA-200c attenuates tu-mour growth and metastasis of presumptive head and neck squa-mous cell carcinoma stem cells[J]. J Pathol, 2011, 223(4):482-495.
[23] Andreassen CN, Alsner J. Genetic variants and normal tissue toxic-ity after radiotherapy:a systematic review[J]. Radiother Oncol, 2009, 92(3):299-309.
[24] Andreassen CN. Searching for genetic determinants of normal tissue radiosensitivity-are we on the right track?[J]. Radiother Oncol, 2010, 97(1):1-8.
[25] West C, Rosenstein BS. Establishment of a radiogenomics consor-tium[J]. Radiother Oncol, 2010, 94(1):117-118.
[26] Hui AB, Lenarduzzi M, Krushel T, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas[J]. Clin Cancer Res, 2010, 16(4):1129-1139.
[27] Chen D, Cabay RJ, Jin Y, et al. MicroRNA deregulations in head and neck squamous cell carcinomas[J/OL]. J Oral Maxillofac Res, 2013, 4(1):e2[2014-11-17]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886106.
[28] Nakanishi H, Taccioli C, Palatini J, et al. Loss of miR-125b-1 con-tributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway[J]. Oncogene, 2014, 33(6):702-712.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]刘凌湘,梁锦钊,张家昌,等.头颈部肿瘤两种放疗体位固定摆位误差分析[J].国际放射医学核医学杂志,2016,40(4):263.[doi:10.3760/cma.j.issn.1673-4114.2016.04.005]
Liu Lingxiang,Liang Jinzhao,Zhang Jiachang,et al.Analysis of setup errors using two immobilization techniques in the radiotherapy of head-and-neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):263.[doi:10.3760/cma.j.issn.1673-4114.2016.04.005]
[6]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[7]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[8]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[9]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[10]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]